Laboratory Services

Health IT Sector Showing High Potential for Accelerated Growth – The health information technology sector is poised to become the next big thing for investors in the health-care industry. The physician practices sector experienced the second-highest growth in July, with an emphasis on certain medical practice areas.

INSIGHT: Strong Health-Care Deal Activity Seen in 2018’s First Half– The first half of 2018 saw a strong wave of M&A and deal making activity across nearly all sectors of the U.S. healthcare industry. The second half of 2018 likely will be just as robust.

What Types of Transactions Could be Right for my Healthcare Services Business?– Episode 3 of Provident’s Healthcare Dealcast

What are the Benefits of Hiring an Investment Banking Firm?– Episode 2 of Provident’s Healthcare Dealcast

Why Is Healthcare Consolidating?– Episode 1 of Provident’s Healthcare Dealcast

Q2-2018 Laboratory Services Update– Increasing demand from patients for advanced technologies and quick, accurate, test results has put pressure on the laboratory services industry to find new and innovative ways to meet a changing healthcare landscape.

Q1-2018 Laboratory Services Update– Uncertainty in the greater healthcare industry continues to trickle down to the laboratory services sector. Questions around the Medicare market-based national fee schedule and the expectation of major payment cuts for laboratory tests looms on the horizon. This reimbursement uncertainty has continued to fuel a robust consolidation market, with many small to mid-sized providers turning to consolidation to fend off industry headwinds.

Q4-2017 Laboratory Services Update– The end of 2017 saw the rich get richer in the laboratory services industry. Many notable players in the industry made sizeable acquisitions.

Q3-2017 Laboratory Services Update– The laboratory services market continues to be dominated by two global providers; LabCorp and Quest Diagnostics. With the Centers for Medicare and Medicaid releasing a draft of 2018 reimbursement rates in September, the industry could see as much as a 10% hits to reimbursement rates across the board. While a decrease was anticipated, this outcome is far worse than anyone expected. The ability to leverage size and scale has allowed the industry’s largest providers to capitalize on this news.

  • “While the decision to sell our business was a difficult one, Provident vigilantly represented and protected our best interests throughout the transaction.  Provident was the right choice for Cascade and I would recommend their services to anyone.”

  • “We would not have been successful navigating the process without Provident’s hard work and active participation. They exceeded our expectations and we would highly recommend them to any health care company seeking a knowledgeable and engaged investment banking firm.”

  • “A lot of investment bankers were interviewed, Provident was chosen. Provident delivered. My clients could not be happier.”

  • “Provident listened to our story, confirmed that our business was valuable and made us feel like this was the only transaction important to them.”

  • “After working with Provident on several transactions, it is evident that their extensive industry knowledge and deal expertise prove to be invaluable to their clients.”

  • “Provident’s depth of experience and practical business savvy was demonstrated in their ability to cut through what sometimes looked like impasse.”

  • ”I have a tremendous amount of appreciation and gratitude to the Provident team for their hard work and diligence throughout this process. Each and every member of the Provident team is excellent at their jobs and it has been a pleasure working with such a professional team. Provident has provided outstanding guidance and counsel, and this deal could never have gotten done without Provident’s leadership.”